Considering that EBV infections express in every situations of NKTL aswell as in some instances of Burkitt lymphoma and DLBCL [105], anti-EBV treatment may complement EZH2-based therapeutics. T cell leukemia/lymphoma, multiple myeloma Among these inhibitors, EPZ-6438 (Tazemetostat) is certainly a representative which has currently entered scientific trial stage I/II for the treating multiple malignancies with […]